Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Bendamustine in Combination With Lenalidomide (CC-5013) and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma

NCT01042704 is registered in ClinicalTrials.gov with Robert Redner, MD as lead sponsor.

NCT NCT01042704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01042704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Bendamustine in Combination With Lenalidomide (CC-5013) and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma
Lead sponsor
Robert Redner, MD
Phase
Phase 1
Overall status
Completed
Start date
February 29, 2008
Completion date
March 31, 2015
Enrollment
29 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

myeloma